Recursion Pharmaceuticals, Inc. Class A Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for RXRX, updated each market day.
RXRX AI Sentiment
AI sees no strong directional signal for Recursion Pharmaceuticals, Inc. Class A Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Recursion Pharmaceuticals, Inc. Class A Common Stock
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.
Sector
Exchange
Market Cap
$1,748,349,646
Cap Tier
Employees
600
Headquarters
SALT LAKE CITY, UT
Listed Since
April 16, 2021
Website
RXRX Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
RXRX Volatility
Recursion Pharmaceuticals, Inc. Class A Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
